| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKAP9 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | SAFB2 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | SCP2 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | HUS1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | CAMSAP2 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | STK24 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | OR7A10 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | AKAP14 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | EGR3 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | PRPH | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
